BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16086725)

  • 21. Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis.
    Wiesner RH; Grambsch PM; Lindor KD; Ludwig J; Dickson ER
    Hepatology; 1988; 8(3):668-76. PubMed ID: 3286461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.
    Kaplan MM; Schmid C; Provenzale D; Sharma A; Dickstein G; McKusick A
    Gastroenterology; 1999 Nov; 117(5):1173-80. PubMed ID: 10535881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
    Raedsch R; Stiehl A; Walker S; Scherrmann JM; Kommerell B
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():55-7. PubMed ID: 1449019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy.
    Zifroni A; Schaffner F
    Hepatology; 1991 Dec; 14(6):990-3. PubMed ID: 1959887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis.
    Goulis J; Leandro G; Burroughs AK
    Lancet; 1999 Sep; 354(9184):1053-60. PubMed ID: 10509495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anabolic-androgenic steroids for alcoholic liver disease.
    Rambaldi A; Iaquinto G; Gluud C
    Cochrane Database Syst Rev; 2003; (1):CD003045. PubMed ID: 12535450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary biliary cirrhosis: how should we evaluate new treatments?
    Goddard CJ; Warnes TW
    Lancet; 1994 May; 343(8909):1305-6. PubMed ID: 7910318
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Am J Gastroenterol; 2005 Nov; 100(11):2583-91. PubMed ID: 16279916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of propylthiouracil for alcoholic liver disease--a Cochrane Hepato-Biliary Group Review.
    Rambaldi A; Gluud C
    Liver; 2001 Dec; 21(6):398-404. PubMed ID: 11903884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine.
    Miettinen TA; Färkkilä M; Vuoristo M; Karvonen AL; Leino R; Lehtola J; Friman C; Seppälä K; Tuominen J
    Hepatology; 1995 May; 21(5):1261-8. PubMed ID: 7737632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of primary biliary cirrhosis.
    Adams D; Clements D; Elias E
    J Clin Hosp Pharm; 1986 Apr; 11(2):65-73. PubMed ID: 3519687
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of primary biliary cirrhosis.
    Babbs C; Smith A; Warnes TW
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1486-7. PubMed ID: 3121074
    [No Abstract]   [Full Text] [Related]  

  • 36. Colchicine in primary biliary cirrhosis.
    Mollengarden GA
    Gastroenterology; 1989 Jun; 96(6):1628-9. PubMed ID: 2714590
    [No Abstract]   [Full Text] [Related]  

  • 37. Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival.
    Morgan TR; Weiss DG; Nemchausky B; Schiff ER; Anand B; Simon F; Kidao J; Cecil B; Mendenhall CL; Nelson D; Lieber C; Pedrosa M; Jeffers L; Bloor J; Lumeng L; Marsano L; McClain C; Mishra G; Myers B; Leo M; Ponomarenko Y; Taylor D; Chedid A; French S; Kanel G; Murray N; Pinto P; Fong TL; Sather MR
    Gastroenterology; 2005 Apr; 128(4):882-90. PubMed ID: 15825072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocytopenia complicating colchicine therapy for primary biliary cirrhosis.
    Finklestein M; Goldman L; Grace ND; Foley M; Randall N
    Gastroenterology; 1987 Dec; 93(6):1231-5. PubMed ID: 3678740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.
    Christensen E; Neuberger J; Crowe J; Altman DG; Popper H; Portmann B; Doniach D; Ranek L; Tygstrup N; Williams R
    Gastroenterology; 1985 Nov; 89(5):1084-91. PubMed ID: 3899841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definitive therapy for primary biliary cirrhosis--fact or fiction?
    Boyer JL
    Gastroenterology; 1988 Jul; 95(1):242-5. PubMed ID: 3371619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.